New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients

Nephrol Dial Transplant. 2008 Jun;23(6):1816-8. doi: 10.1093/ndt/gfn052. Epub 2008 Mar 8.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Age of Onset
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / etiology*
  • Diabetes Mellitus / prevention & control
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Incidence
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / immunology
  • Male
  • Risk Assessment
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects
  • Transplantation Immunology / physiology

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus